按首字母搜索

Cas号索引 1

• 1260251-31-7 | Birinapant (Catalog# : 185182)Birinapant，也被称为TL32711，是一种合成的小分子，具有潜在的抗肿
• 1286279-29-5 | BMS-813160 (Catalog# : 1842812)BMS-813160是一种有效的选择性CCR2/CCR5拮抗剂，具有潜在的免疫调节
• 198480-56-7 | 盐酸巴多昔芬 (Catalog# : 18496)Bazedoxifene，又名WAY-140424，是第三代选择性雌激素受体调节剂(SERM)
• 1513879-21-4 | BQR695 (Catalog# : 184218)BQR695, also known as NVP-BQR695, is a potent and selective PI4K inhibitor.
• 1414943-88-6 | BAY1143572 (Catalog# : 181242)Atuveciclib, also known as BAY1143572, is a highly selective, potent and orally avail
• 1803274-65-8 | BAY-1436032 (Catalog# : 181181)BAY-1436032是一个强有力的,有选择性的，有效的突变异柠檬酸脱氢酶
• 1446090-77-2;1446090-79-4 | BGB-283 (Catalog# : 17101620)BGB-283，也称为Beigene-283或Lifirafenib，是一种新的有效的和选择性的
• 1357920-84-3 | Belizatinib (Catalog# : 17101619)Belizatinib，也称为TSR-011，具有受体酪氨酸激酶间变性淋巴瘤激酶（
• 1420071-30-2 | Bioymifi (Catalog# : 1710165)Bioymifi是DR5的活性剂(Kd = 1.2 µM; IC50 = 2 µM). Bioymifi诱导凋亡的肿瘤
• 1707289-21-1 | BLU-554 (Catalog# : 1710162)BLU-554是针对肝癌治疗的成纤维细胞生长因子受体4（FGFR4）抑制剂
• 1632118-69-4 | BAR-501 (Catalog# : 179821)BAR-501是一种选择性GPBAR1激动剂，没有任何的FXR激动剂活性。BAR-50
• 1207293-36-4 | BI-847325 (Catalog# : 83101)BI-847325是一种口服、具有选择性的日常生物MEK/Aurora激酶抑制剂，
• 1906919-67-2 | BAY-598 (Catalog# : 17982)BAY-598是一种强效的针对SMYD2中肽-竞争的化学探测器。BAY-598拥有一
• 1906920-28-2 | BAY-598 R-异构体 (Catalog# : 17981)BAY-598 R-异构体是BAY589 R-异构体。bay-598 R-异构体可以作为一个参照
• 171655-91-7 | 布索芬新 (Catalog# : 17916)布索芬新是一种充分的单胺再摄取阻滞剂，已被开发用于治疗帕金
• 1290541-46-6 | B02 (Catalog# : 1783013)B02，也叫RAD51 - in - 02，是一种RAD51抑制剂。B02能增强MM细胞的DOX敏
• 1703793-34-3 | BLU-285 (Catalog# : 1781003)BLU-285是一种有效、具有选择性的抑制剂。
• 1876467-74-1 | BAY-1895344 (Catalog# : 1781002)BAY-1895344是一种有效的、具有选择性的ATM抑制剂。
• 1263871-36-8 | BMS-932481 (Catalog# : 2017877)BMS-932481调节Aβ肽在血浆和脑脊液的健康志愿者。
• 1334493-07-0 | BP-1-102 (Catalog# : 17030606)BP-1-102是一种有效的口服生物和选择性抑制剂。
• 1799753-84-6 | BAY-876 (Catalog# : 17030604)BAY-876是一种有效的、选择性的谷氨酸抑制剂。BAY- 876在体外具有良
• 1137359-47-7 | BRD-7552 (Catalog# : 17030312)BRD-7552是一种PDX1转录诱导因子。它主要在人类胰岛和导管细胞中调
• 1821496-27-8 | BDA-366 (Catalog# : 17030305)BDA - 366是BCL - BH4拮抗剂。BDA - 366抑制人骨髓瘤的生长。BDA - 366诱导
• 1225037-39-7 | Bimiralisib (Catalog# : 17030116)Bimiralisib，也被称为PQR309，是一种口服生物可用的磷脂- 3 -激酶抑
• 1197953-54-0 | Brigatinib (AP-26113) (Catalog# : 16122905)Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual AL
• 189232-42-6 | Bohemine (Catalog# : 16122903)Bohemine is a potent and selective, cell-permeable, cyclin-dependent kinase (CDK) inh
• 1000998-59-3 | BMS-687453 (Catalog# : 16122902)BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR
• 130370-60-4 | Batimastat (Catalog# : 16122804)Batimastat (also known as BB-94) is a synthetic matrix metalloproteinase inhibitor th
• 1909226-00-1 | BDA-366 (Catalog# : 16122769)BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affini
• 1883429-21-7 | BI-7273 (Catalog# : 16122742)BI-7273 is a potent, selective, and cell-permeable BRD9 BD Inhibitor.